AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Alprostadil Cream treatment for female sexual arousal disorder to be presented.
2004 SEP 22 - (NewsRx.com & NewsRx.net) -- NexMed, Inc., (NASDAQ:NEXM) announced that it will present the new findings of a pilot clinical study conducted offshore, entitled "A Pilot Clinical Study of a Topical Alprostadil Cream for the Treatment of Female Sexual Arousal Disorder (FSAD)."
The presentation will take place at the Annual Meeting of the International Society for the Study of Women's Sexual Health on October 28-31, 2004, in Atlanta, Georgia. Femprox is NexMed's proprietary FSAD treatment under development and incorporates alprostadil (PGE) with the patented NexACT technology.
This was a randomized, placebo-controlled, double-blind, crossover clinical study that tested eight female patients, 21-45 years of age, diagnosed with FSAD (as defined by their sexual history, Female Sexual Distress Scale, and psychological assessment) for more than 6 months. The subjects received both a placebo cream and Femprox.
The primary efficacy end point was measured as the score of the arousal success or the number of the "Yes" responses to question 3 of the female sexual ...
- Data On Nexmed's Topical Alprostadil Cream Presented At the 8th World Meeting...
- Press release article from: Business Wire September 1, 1998 700+ words
...medical device company, is developing 1) Alprox-TD(TM) and Femprox(TM), topically-applied treatments for male and female sexual dysfunction; 2) Viratrol(R), a non-invasive, hand-held device for treating oral and genital herpes; 3) a generic...
- Research conducted at Q.P. Liao and co-authors has provided new information...
- Magazine article from: Women's Health Weekly September 4, 2008 700+ words
...treatment changes in Female Sexual Distress Scale. A total...and colleagues (see also Female Sexual Arousal Disorder). The...Efficacy and safety of alprostadil cream for the treatment of female sexual arousal disorder: A double...
- NexMed's Female Sexual Arousal Disorder Product Enters Phase 2 Clinical Trial.
- Press release article from: PR Newswire May 21, 2001 700+ words
...Femprox(TM), a topical treatment under development for female sexual arousal disorder ("FSAD"). The Phase 2 study is randomized...The Company is also developing Alprox-TD(R), an alprostadil cream treatment for ED, which was recently approved for sale...
- NexMed to Present Poster on Femprox at the American Urological Association...
- Press release article from: PR Newswire May 19, 2005 700+ words
...Findings Link the Use of Alprostadil Cream to Female Sexual Arousal Response - ROBBINSVILLE...poster entitled, "Effect of Alprostadil Cream on Cerebral Responses using...cream, for treatment of female sexual arousal disorder ('FSAD...
- NexMed Selected for Two Abstract and Two Podium Presentations During...
- Press release article from: PR Newswire March 27, 2003 700+ words
...A Novel Topical Alprostadil Cream for the Treatment...entitled "Treatment Of Female Sexual Arousal Disorder...Using A Novel Topical Alprostadil Cream: A Phase 2 Clinical...cream treatment for female sexual arousal disorder...
- NexMed Selected for Poster Presentation During The Int'l Society for the Study...
- Press release article from: PR Newswire August 25, 2004 700+ words
...Clinical Study of a Topical Alprostadil Cream for the Treatment of Female Sexual Arousal Disorder (FSAD...their sexual history, Female Sexual Distress Scale, and...to Question 3 of the Female Sexual Encounter Profile (FSEP...
- NexMed Confirms Publication of New Femprox(R) Data in The Journal of Sexual...
- Press release article from: Business Wire August 4, 2008 700+ words
...topical treatment for female sexual arousal disorder, was...Efficacy and Safety of Alprostadil Cream for the Treatment of Female Sexual Arousal Disorder: A...Phase 2 treatment for female sexual arousal disorder, and...
- NexMed Announces Upcoming Presentations.
- Press release article from: PR Newswire October 7, 2005 700+ words
...in patients with female sexual arousal disorder...formulated topical alprostadil cream by a continuous dosing...the treatment of female sexual arousal disorder...specially formulated alprostadil cream on the hypothelamic...
- NexMed Publishes Positive Results for Femprox(R) in Journal of Sex & Marital...
- Press release article from: PR Newswire October 7, 2003 700+ words
...NexMed's proprietary cream treatment for female sexual arousal disorder ("FSAD"), has been...entitled "Efficacy and Safety of Topical Alprostadil Cream for the Treatment of Female Sexual Arousal Disorder (FSAD): A Double-Blind...
- NexMed Presents Clinical Data On Proprietary Topical Treatments for Sexual...
- Press release article from: Business Wire September 8, 1999 700+ words
...entitled "Clinical Evaluations of a New Alprostadil Cream for Treating Male and Female Sexual Dysfunction" at the 59th International...topically-applied treatments for male and female sexual dysfunction; and 2) Viratrol, a non...
Source: HighBeam Research, Alprostadil Cream treatment for female sexual arousal disorder to be...